ArticleEndocrine pathology2025
A Novel Three-Stage AI-Assisted Approach for Accurate Differential Diagnosis and Classification of NIFTP and Thyroid Neoplasms.
Article in Endocrine pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Autoimmune thyroiditis and comorbid autoimmune diseases: global research landscape and future directions.Frontiers in immunology · 2026Pooled it
- Deep Learning-Based Classification of NIFTP and Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma Using Gross Pathology Images.Journal of imaging informatics in medicine · 2026Article
- A vision-language foundation model improves preoperative diagnosis of follicular thyroid neoplasms using ultrasound images.NPJ precision oncology · 2026Article
- From Tissue Architecture To Genetic Signature: Artificial intelligence-based Analysis of Reticulin Framework and Clinical Variables Predicts Molecular Cluster in Paragangliomas.Endocrine pathology · 2026Article
- Ultrasound features of thyroid follicular adenoma and follicular carcinoma: A narrative review.The Journal of international medical research · 2026Review
- MiThyCA: A Computational Pathology Pipeline for the Identification of Microscopic Foci of Papillary Thyroid Carcinoma-Like Nuclear Features with AI in Whole-Slide Histological Images.Endocrine pathology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The recent introduction of the term non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) marked a pivotal shift in the classification of encapsulated follicular variant of papillary thyroid carcinoma (EFVPTC) lacking invasive features. While its reclassification from the "malignant" to "low-risk neoplasm" category significantly reduced overtreatment, its histopathological diagnosis remains challenging due to overlapping features with other thyroid lesions and inter-observer variability. Artificial intelligence (AI) overcomes such key limitations of histopathological evaluation, ensuring a robust and efficient diagnostic process. While preliminary studies are promising, AI models capable of efficiently distinguishing NIFTP from other benign and malignant thyroid entities are yet to be developed. We devised an innovative AI-based three-stage hierarchical pipeline that systematically evaluates architectural patterns and nuclear features. The prioritized models were trained using 154,498 patches, derived from 134 sections prepared from 125 thyroid nodules, representing follicular nodular disease (FND), follicular adenoma, dominant nodule in FND, invasive EFVPTC (IEFVPTC), and classic and infiltrative follicular subtypes of PTC. External validation revealed good accuracy at the overall, patient-wise, and class-wise levels. However, it showed limitations in the differential diagnosis of NIFTP from IEFVPTC-an expected challenge due to overlapping nuclear features and the absence of incorporating the assessment of the tumor capsule for invasive characteristics. While the novel approach and the algorithm show promise in transforming histopathological NIFTP diagnostics, further improvements and rigorous validations are necessary before considering its application in real-world clinical settings.
Indexed as
Identifiers
40531372What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.